Cargando…
EBAG9 controls CD8(+) T cell memory formation responding to tumor challenge in mice
Insight into processes that determine CD8(+) T cell memory formation has been obtained from infection models. These models are biased toward an inflammatory milieu and often use high-avidity CD8(+) T cells in adoptive-transfer procedures. It is unclear whether these conditions mimic the differentiat...
Autores principales: | Rehm, Armin, Wirges, Anthea, Hoser, Dana, Fischer, Cornelius, Herda, Stefanie, Gerlach, Kerstin, Sauer, Sascha, Willimsky, Gerald, Höpken, Uta E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220939/ https://www.ncbi.nlm.nih.gov/pubmed/35482418 http://dx.doi.org/10.1172/jci.insight.155534 |
Ejemplares similares
-
EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effects
por: Wirges, Anthea, et al.
Publicado: (2022) -
Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker
por: Reimer, Tatiana A, et al.
Publicado: (2005) -
Accelerating clinical-scale production of BCMA CAR T cells with defined maturation stages
por: Joedicke, Jara J., et al.
Publicado: (2021) -
CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells
por: Bunse, Mario, et al.
Publicado: (2021) -
Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth
por: Menzel, Lutz, et al.
Publicado: (2020)